FR EA
1019-00005 · Whitmore Aerospace LLC · Budget and Administration
revised-litigation-budget-memo.xlsx DOCUMENT Litigation
9 / 35 ← → ✕
Contract analysis Extract to table

[sheet: Cover]

FieldValue
Document TitleRevised Litigation Budget Memorandum
DateApril 15, 2023
Prepared ByDouglas Carmichael, Billing Partner, Calderwood & Harkness LLP
ToGregory Poole, General Counsel & VP Legal Affairs, Whitmore Aerospace LLC
FromDouglas Carmichael, Calderwood & Harkness LLP
CCPriya Anand, Responsible Partner; Patrick Gallagher, Lead Associate
ReWhitmore Aerospace LLC v. Hargrove-Dalton Defense Systems, Inc., No. 1:22-cv-10147-RMB (S.D.N.Y.) — Revised Litigation Budget
ClientWhitmore Aerospace LLC
Client Address4200 Commerce Park Drive, Suite 600, Chantilly, VA 20151
FirmCalderwood & Harkness LLP
Firm Address600 Lexington Avenue, 28th Floor, New York, NY 10022
Engagement Letter DateNovember 1, 2022
Matter StatusDormant — Case stayed by Order of Hon. Richard M. Brannigan dated March 17, 2023, pending conclusion of DCMA administrative review
Original Budget Estimate (per Engagement Letter)$1,800,000 – $2,400,000 (through trial)
PurposeTo revise the litigation budget to reflect reduced activity following the court-ordered stay and to provide updated phase-by-phase cost projections incorporating dormancy-period monitoring costs
Amount in Controversy$14,726,583 (HDDS indemnification demand)
Underlying ContractPrime Contract No. FA8620-19-C-0337 (Advanced Tactical Airframe Program)
Teaming Agreement DateJune 12, 2019
Governing LawNew York
ConfidentialityAttorney-Client Privileged / Attorney Work Product

[sheet: Billing Rates]

TimekeeperTitle / RoleOfficeHourly RateExperience
Priya AnandResponsible PartnerNew York$1,15018 years — complex commercial litigation & government-contracts disputes
Douglas CarmichaelBilling PartnerNew York$1,15022 years — co-chair, Government Contracts & Procurement Disputes practice
Patrick GallagherLead AssociateNew York$7256 years — litigation
Simone LarocheWorking AssociateWashington, D.C.$5753 years — litigation; BS Aerospace Engineering, Virginia Tech

[sheet: Fees Incurred to Date]

PhaseDescriptionPeriodKey ActivitiesFees Incurred
Phase 1: Pre-Filing Investigation & Complaint DraftingReview of Teaming Agreement (dated June 12, 2019), analysis of Section 11.4 indemnity clause and Section 11.5 liability cap ($88,992,000 = 120% × $74,160,000 WP-4 value), review of DCMA COPD dated August 1, 2022, analysis of HDDS indemnification demand ($14,726,583), preparation and filing of Verified Complaint for Declaratory Judgment (28 U.S.C. §§ 2201–2202), Civil Cover Sheet (JS 44), and SummonsNov. 1, 2022 – Nov. 28, 2022Engagement letter execution (Nov. 1, 2022); conflict check (Oct. 28, 2022); litigation hold notice (Nov. 2, 2022); preliminary case assessment memo (Nov. 7, 2022); indemnity clause analysis memo (Nov. 14, 2022); complaint drafting and filing (Nov. 28, 2022)$112,400
Phase 2: Motion Practice — StayPreparation and filing of Memorandum of Law in Support of Motion to Stay (Feb. 10, 2023); Declarations of Catherine Soo-Hyun Park and Priya Anand; Joint Stipulation and Proposed Order filed Feb. 24, 2023; Court granted stay March 17, 2023 (Hon. Richard M. Brannigan)Jan. 13, 2023 – Mar. 17, 2023Analysis of HDDS Answer and Counterclaim (filed Jan. 13, 2023; counterclaim: $14,726,583 + attorneys' fees under § 11.6); Reply to Counterclaim (filed Feb. 3, 2023); motion to stay briefing; coordination with Voss, Trager & Kendall LLP (Leonard Trager / Megan Forsythe) on joint stipulation$68,750
Phase 3: Insurance Tender & CoverageTender of HDDS indemnity demand to Meridian Surety & Insurance Group (D&O Policy No. MSI-DO-2022-07814, $10M aggregate, $250K retention; CGL Policy No. MSI-CGL-2021-33291, $25M aggregate, $500K SIR); analysis of Meridian reservation-of-rights letter (Nov. 1, 2022) reserving on contractual-liability exclusion (Exclusion (b)) and government-contract exclusion (Endorsement GC-04); follow-up correspondence (Mar. 10, 2023)Sept. 22, 2022 – Mar. 10, 2023Tender letter to Rachel Underwood at Meridian (Sept. 22, 2022); internal memo analyzing ROR letter (Nov. 15, 2022); follow-up letter requesting definitive coverage determination (Mar. 10, 2023); Meridian not providing defense or funding DJ action$37,500
Phase 4: Lender Notification & ComplianceNotification to Ridgeline National Bank, N.A. (David Kreutz, SVP) under Section 6.07(b) of $75M senior secured revolving credit facility (dated Mar. 15, 2021) — claims exceeding $5M threshold; supplemental notice re DJ filingSept. 28, 2022 – Dec. 5, 2022Initial Section 6.07(b) notice (Sept. 28, 2022); supplemental notice re DJ action filing (Dec. 5, 2022); no event of default; facility fully available; $31.2M currently drawn$12,500
Phase 5: Administrative Proceeding Monitoring & CoordinationMonitoring DCMA administrative review of cost overruns under Prime Contract FA8620-19-C-0337; coordination with Ashford & Reeves LLP (Harold Reeves, Natalie Cheng) re DCMA process under Contract Disputes Act; analysis of COPD allocation (WP-4: $12,817,441 / 87.03%; non-WP-4: $1,909,142 / 12.97%); coordination protocol letter (Jan. 5, 2023)Nov. 2022 – Apr. 15, 2023DCMA COPD analysis; memo re DCMA administrative process and implications for DJ action (Dec. 20, 2022); coordination protocol with Ashford & Reeves (Jan. 5, 2023); ongoing monitoring of ACO Lt. Col. Sandra M. Vickers status$43,670
Phase 6: Miscellaneous — Client Communications & Document PreservationRegular client updates to Marcus J. Whitmore (CEO), Gregory Poole (GC), Catherine Soo-Hyun Park (VP Gov't Contracts); document preservation oversight; ASC 450 coordination with Pinnacle Advisory Partners LLC (Thomas Brennan, CPA)Nov. 2022 – Apr. 15, 2023Litigation hold management; client strategy calls; coordination re FY 2022 audit contingent liability footnote (reasonably possible, up to $14.7M, no accrual)$25,000
TOTAL FEES INCURRED TO DATENov. 1, 2022 – Apr. 15, 2023$299,820

[sheet: Projected Budget]

Phase / CategoryDescriptionEstimated DurationLow EstimateHigh EstimateAssumptions / Notes
Dormancy-Period Monitoring (Annual)Joint status reports to court every 120 days (~3 per year at avg. $12,500 each = ~$37,500/yr); ongoing DCMA administrative review monitoring and coordination with Ashford & Reeves LLP (~$50,000/yr); insurance coverage follow-up with Meridian (~$7,500/yr); miscellaneous client communications (~$5,000/yr)Apr. 2023 – until COFD issued (est. 1–3 years)$100,000/yr$120,000/yrAssumes stay remains in effect; minimal motion practice; 120-day status report cycle per Mar. 17, 2023 stay order (Hon. Brannigan); ACO Lt. Col. Vickers has not indicated COFD timeline
Dormancy Period — Year 1 (Apr. 2023 – Mar. 2024)Status reports (3); DCMA monitoring; Ashford & Reeves coordination; insurance follow-up12 months$100,000$120,000Includes first three status reports (Jul. 15, 2023; Nov. 12, 2023; Mar. 11, 2024)
Dormancy Period — Year 2 (Apr. 2024 – Mar. 2025)Status reports (3); DCMA monitoring; Ashford & Reeves coordination; insurance follow-up; settlement posture analysis12 months$100,000$120,000Includes status reports 4–6 (Jul. 9, 2024; Nov. 6, 2024; Mar. 6, 2025); may include settlement analysis work
Dormancy Period — Year 3 (if needed, Apr. 2025 – Mar. 2026)Continued monitoring if COFD still pending12 months$100,000$120,000Contingent; may not be needed if COFD issues sooner
Litigation Reactivation — Motion to Lift Stay & Case ManagementMotion to lift stay or respond to COFD issuance; initial case management conference with Magistrate Judge Kurtz; revised scheduling order1–2 months$25,000$40,000Triggered by issuance of COFD by DCMA or by party motion
Fact discoveryDocument requests and production; interrogatories; depositions (estimated 8–12 depositions including HDDS personnel William Fong, Renee Aldrich; WAL personnel; DCMA witnesses if available); ESI review6–9 months$350,000$500,000Significant volume anticipated re: WP-4 cost overrun root causes — Ti material escalation ($4.2M), rework/non-conforming tolerances ($5.1M), idle labor/schedule delays ($2.3M), ECP costs ($1.2M); HDDS-supplied engineering specs; government-furnished equipment delays
Expert discoveryRetention and reports from damages expert and government-contracts accounting expert; expert depositions (2–4)3–4 months$150,000$225,000Experts needed on: (1) cost-overrun causation and allocation; (2) CPIF contract accounting (70/30 overrun share ratio); (3) reasonableness of WP-4 costs
Summary Judgment / Dispositive MotionsPotential motion for partial summary judgment on non-WP-4 overruns ($1,909,142 — no conceivable WAL liability); potential cross-motions on Section 11.4(b) causation and Section 11.5 cap interpretation2–3 months$175,000$250,000Strong candidate for partial SJ on non-WP-4 component; briefing on causation requirement under New York law
Pre-Trial PreparationPre-trial motions in limine; pre-trial memoranda; witness preparation; trial binders; jury instructions (if applicable — likely bench trial given contract dispute)2–3 months$125,000$200,000Bench trial before Hon. Richard M. Brannigan likely
TrialEstimated 5–7 day bench trial in S.D.N.Y.1–2 weeks$200,000$300,000Assumes bench trial; amount could increase if HDDS seeks jury on counterclaim
Post-Trial Motions & Appeal ReservePost-trial briefing; potential appeal to Second Circuit3–12 months$75,000$150,000Reserve estimate; appeal costs highly variable
SUBTOTAL — Dormancy Period (2 years est.)$200,000$240,0002 years × $100K–$120K/yr
SUBTOTAL — Active Litigation (Post-Reactivation through Trial)$1,100,000$1,665,000Sum of reactivation ($25K) + fact discovery ($350K) + expert discovery ($150K) + summary judgment ($175K) + pre-trial ($125K) + trial ($200K) + post-trial/appeal ($75K)
TOTAL PROJECTED REMAINING FEES$1,300,000$1,905,000Dormancy ($200,000) + Active Litigation ($1,100,000) = $1,300,000 Low; Dormancy ($240,000) + Active Litigation ($1,665,000) = $1,905,000 High
TOTAL ESTIMATED MATTER COST (Incurred + Projected)$1,599,820$2,204,820Fees incurred to date ($299,820) + projected remaining ($1,300,000–$1,905,000); original engagement letter estimate was $1,800,000–$2,400,000

[sheet: Budget Comparison]

CategoryOriginal Estimate — LowOriginal Estimate — HighRevised Estimate — LowRevised Estimate — HighVariance — LowVariance — HighNotes
Pre-Filing & Complaint$100,000$125,000$112,400 (actual)$112,400 (actual)+$12,400-$12,600Actual exceeded low estimate due to detailed Section 11.4 analysis; under high estimate
Answer/Counterclaim Response & Stay Motion$75,000$100,000$68,750 (actual)$68,750 (actual)-$6,250-$31,250Under budget — joint stipulation reduced briefing costs
Insurance & Lender Compliance$40,000$60,000$50,000 (actual)$50,000 (actual)+$10,000-$10,000Within range; combined Phase 3 ($37,500) + Phase 4 ($12,500)
DCMA Monitoring & Coordination (pre-stay)$30,000$50,000$43,670 (actual)$43,670 (actual)+$13,670-$6,330Within range
Miscellaneous / Client Communications$20,000$30,000$25,000 (actual)$25,000 (actual)+$5,000-$5,000Within range
Dormancy-Period Monitoring (not in original)$0$0$200,000$360,000+$200,000+$360,000New category — not contemplated in original budget; $100K–$120K/yr × 2–3 years
Fact discovery$400,000$550,000$350,000$500,000-$50,000-$50,000Reduced: DCMA COFD expected to narrow factual issues
Expert discovery$175,000$250,000$150,000$225,000-$25,000-$25,000Slightly reduced
Summary Judgment$200,000$275,000$175,000$250,000-$25,000-$25,000Slightly reduced — partial SJ on non-WP-4 overruns strong
Pre-Trial & Trial$350,000$500,000$325,000$500,000-$25,000$0Comparable; includes reactivation costs ($25K–$40K) in revised estimate
Post-Trial / Appeal Reserve$75,000$150,000$75,000$150,000$0$0Unchanged
TOTAL$1,800,000$2,400,000$1,599,820$2,204,820-$200,180-$195,180Revised estimate within or below original range; dormancy costs offset by anticipated reductions in active litigation phases due to narrowing effect of COFD

[sheet: Exposure Summary]

ItemAmountReference / Notes
HDDS Indemnification Demand (Total)$14,726,583Per HDDS demand letter dated September 9, 2022; equals full COPD amount
COPD — WP-4 Overruns (87.03%)$12,817,441Attributable to WAL's Work Package 4 (titanium structural assemblies)
COPD — Non-WP-4 Overruns (12.97%)$1,909,142Not attributable to WAL; WAL contends no liability for this portion
WP-4 Overrun: Titanium Material Escalation$4,200,000Approx. per COPD narrative; WAL asserts force-majeure defense
WP-4 Overrun: Rework (Non-Conforming Tolerances)$5,100,000Approx. per COPD narrative; WAL asserts HDDS-supplied specifications caused rework
WP-4 Overrun: Idle-Labor / Schedule Delays$2,300,000Approx. per COPD narrative; WAL asserts HDDS late delivery of gov't-furnished equipment
WP-4 Overrun: ECP Implementation$1,200,000Approx. per COPD narrative
WP-4 Overrun Subtotal (approx.)$12,800,000Sum of Ti escalation ($4.2M) + rework ($5.1M) + idle labor ($2.3M) + ECP ($1.2M); narrative rounding per COPD
Section 11.5 Indemnity Cap (120% of WP-4 Value)$88,992,000$74,160,000 × 1.20; maximum theoretical exposure under Teaming Agreement
WAL Work Package 4 Value (18% of Target Cost)$74,160,000$412,000,000 × 0.18
Prime Contract Target Cost$412,000,000CPIF contract; target fee 8% ($32,960,000); ceiling price $470,000,000
Prime Contract Target Fee (8%)$32,960,000$412,000,000 × 0.08
Prime Contract Ceiling Price$470,000,000Maximum allowable cost + fee under CPIF structure
CPIF Share Ratio — Overruns70% Gov't / 30% ContractorPer Prime Contract FA8620-19-C-0337
D&O Policy — Aggregate Limit$10,000,000Meridian Surety & Insurance Group, Policy No. MSI-DO-2022-07814; $250,000 retention
CGL Policy — Aggregate Limit$25,000,000Meridian Surety & Insurance Group, Policy No. MSI-CGL-2021-33291; $500,000 SIR
Insurance Coverage StatusUncertain — ROR issuedMeridian ROR letter dated Nov. 1, 2022; reserves on contractual-liability exclusion (Exclusion (b)) and gov't-contract exclusion (Endorsement GC-04); no defense or funding provided
WAL Credit Facility (Ridgeline National Bank, N.A.)$75,000,000$75M senior secured revolving facility dated Mar. 15, 2021; $31,200,000 currently drawn; Section 6.07(b) notice delivered Sept. 28, 2022 and Dec. 5, 2022; no event of default
WAL FY 2022 Revenue$287,000,000Per audited financial statements (Pinnacle Advisory Partners LLC)
ASC 450 TreatmentReasonably possible; no accrualContingent liability of up to $14.7M disclosed in footnotes to FY 2022 audited financials; assessment unchanged for FY 2023